News | April 29, 2019
Excess weight is a contributing factor for developing psoriasis, and the greater the body mass index (BMI), the higher the chance of getting the disease, according to a new study. To investigate the causal relationship between BMI and...
News | May 23, 2019
The FDA has approved Mayne Pharma Group Limited's Sorilux (calcipotriene) Foam, 0.005% in adolescents 12 years and older. The FDA approved Sorilux in 2010 based on evidence from two eight-week placebo controlled clinical trials in...
News | May 7, 2019
Coming off an impressive inaugural meeting in 2018, the second annual Aesthetics Innovation Summit will unite over 300 of the most influential corporate, capital, and clinical leaders in New Orleans to collaborate on the development and...
News | April 28, 2019
Xstrahl Medical is launching its latest superficial radiotherapy treatment system to treat the full range of non-melanoma skin cancer cases. The new Xstrahl 150 system offers several features that enhance the capabilities of...
News | May 16, 2019
Nestlé has entered into exclusive negotiations with a consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for the sale of Nestlé Skin Health for a value of CHF 10.2 billion....
Acquisitions and Mergers
Business of Medicine
Earnings and Financials
Phase 3/4 Trials
Product Launches and Updates
Research and Publications
Skin of Color
Hispanic and Black Children More Likely to Miss School Due to Eczema Than White Children
Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIA
ISDIN Teams Up with The Claire Marie Foundation And The Ulman Foundation For Skin Cancer Awareness Month
Obagi Launches SKINCLUSION Initiative to Celebrate Diversity with Brand Ambassador Priyanka Chopra Jonas
Abeona Therapeutics to Present EB-101 Data at Society for Investigative Dermatology Annual Meeting